Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells

被引:99
作者
Hoffmann, Jan [1 ]
Paul, Angela [1 ]
Harwardt, Marc [3 ]
Groll, Juergen [2 ,3 ]
Reeswinkel, Thomas [3 ]
Klee, Doris [3 ]
Moeller, Martin [3 ]
Fischer, Heike [4 ]
Walker, Tobias [1 ]
Greiner, Tim [5 ]
Ziemer, Gerhard [1 ]
Wendel, Hans P. [1 ]
机构
[1] Univ Tubingen, Dept Thorac Cardiac & Vasc Surg, D-72074 Tubingen, Germany
[2] SusTech GmbH & Co KG, D-64287 Darmstadt, Germany
[3] Rhein Westfal TH Aachen, Dept Text & Macromol Chem, Aachen, Germany
[4] Jotec AG, Hechingen, Germany
[5] Univ Tubingen Hosp, Dept Lab Anim Med Vet Serv, Tubingen, Germany
关键词
aptamer; whole-cell-SELEX; endothelial precursor cell; drug delivery;
D O I
10.1002/jbm.a.31309
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Because of their insufficient biocompatibility and high thrombogenicity, small diameter artificial vascular prostheses still do not show a satisfactory patency rate. In vitro endothelialization of artificial grafts before implantation has been established experimentally years ago, but, this procedure is extremely time consuming and expensive. This study deals with the coating of graft surfaces with capture molecules (aptamers) for circulating endothelial progenitor cells (EPCs), mimicking a prohoming substrate to fish out EPCs from the bloodstream after implantation and to create an autologous functional endothelium. Using the SELEX technology, aptamers with a high affinity to EPCs were identified, isolated, and grafted onto polymeric discs using a blood compatible star-PEG coating. A porcine in vitro model that demonstrates the specific adhesion of EPCs and their differentiation into vital endothelial-like cells within 10 days in cell culture is presented. We suggest that the rapid adhesion of EPCs to aptamer-coated implants could be useful to promote endothelial wound healing and to prevent increased neo-intimal hyperplasia. We hypothesize that future in vivo self-endothelialization of blood contacting implants by homing factor mimetic capture molecules for EPCs may bring revolutionary new perspectives towards clinical applications of stem cell and tissue engineering strategies. (C) 2007 Wiley Periodicals, Inc. J Biomed Mater Res.
引用
收藏
页码:614 / 621
页数:8
相关论文
共 34 条
  • [1] Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels - Selective targeting of endothelial regulatory protein pigpen
    Blank, M
    Weinschenk, T
    Priemer, M
    Schluesener, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (19) : 16464 - 16468
  • [2] Boyle EM, 1997, ANN THORAC SURG, V63, P277
  • [3] Nucleic acid aptamers in cancer medicine
    Cerchia, L
    Hamm, J
    Libri, D
    Tavitian, B
    de Franciscis, V
    [J]. FEBS LETTERS, 2002, 528 (1-3): : 12 - 16
  • [4] CHANDLER AB, 1958, LAB INVEST, V7, P110
  • [5] CHARACTERIZATION OF CD34(+)HLA-DR(-)CD38(+) AND CD34(+)HLA-DR(-)CD38(-) PROGENITOR CELLS FROM HUMAN UMBILICAL-CORD BLOOD
    CICUTTINI, FM
    WELCH, K
    BOYD, AW
    [J]. GROWTH FACTORS, 1994, 10 (02) : 127 - 134
  • [6] INVITRO SELECTION OF RNA MOLECULES THAT BIND SPECIFIC LIGANDS
    ELLINGTON, AD
    SZOSTAK, JW
    [J]. NATURE, 1990, 346 (6287) : 818 - 822
  • [7] Nucleic acid aptamers - From selection in vitro to applications in vivo
    Famulok, M
    Mayer, G
    Blind, M
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2000, 33 (09) : 591 - 599
  • [8] Fukuda K, 1997, Nucleic Acids Symp Ser, P237
  • [9] Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes
    Gorbet, MB
    Sefton, MV
    [J]. BIOMATERIALS, 2004, 25 (26) : 5681 - 5703
  • [10] Aptamer-based capture molecules as a novel coating strategy to promote cell adhesion
    Guo, K
    Wendel, HP
    Scheideler, L
    Ziemer, G
    Scheule, AM
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2005, 9 (03) : 731 - 736